Effective April 1, 2022, Dr. Meinrad Lugan will change from the B. Braun SE Executive Board to the Executive Board of affiliated company B. Braun Familienholding Verwaltungs SE at his own request as part of a planned generational change. Dr. Lugan is thus giving up his responsibilities for the Hospital Care division.
In his new role, Dr. Lugan will be responsible primarily for the evaluation and development of new technologies and strategic partnerships for the B. Braun Group. Responsibility for the Hospital Care division on the B. Braun SE Executive Board and the position of chairman of the Executive Board of B. Braun Melsungen AG will pass to Markus Strotmann, who is currently responsible on the Executive Board of B. Braun SE for the B. Braun Avitum division and is chairman of the Executive Board of B. Braun Avitum AG. Anna Maria Braun, CEO of B. Braun SE will take on Strotmann’s current duties temporarily.
Dr. Lugan has been on the Executive Board of the B. Braun Group since 2000, where he was initially responsible for the OPM division. Starting in November 2004, he also took on responsibility for the Hospital Care division. From then on, Dr. Lugan led both divisions with great success.
“Under Dr. Lugan’s leadership, the Hospital Care and OPM divisions have become leading providers on the hospital market and in the outpatient sector. Hospital Care is the B. Braun Group’s strongest division in terms of sales. With his excellent knowledge of the medical technology field and of international health care markets, Dr. Lugan has been shaping the development of the B. Braun Group for over 20 years. I thank him sincerely for his outstanding contribution and wish him all the best in his new role,” said Prof. Dr. Thomas Rödder, Chairman of the Supervisory Board of B. Braun SE.
Prof. Dr. h.c. Ludwig Georg Braun, Chairman of the Supervisory Board of B. Braun Familienholding Verwaltungs SE, welcomed Dr. Lugan’s transition, “We’re thrilled to be able to welcome Dr. Lugan to the Executive Board of B. Braun Familienholding Verwaltungs SE as a new member to represent the technology field with outstanding expertise and a wealth of experience that will only benefit this body’s work.”
Markus Strotmann joined the B. Braun Group in 2002. Since 2003, he has been responsible for the Hospital Care division’s strategic marketing and, since December 2008, the division’s sales operations. In 2012, Strotmann was appointed to the Executive Board of B. Braun SE to be responsible for the B. Braun Avitum division as well as to the position of chairman of the Executive Board of the B. Braun Avitum division.
Back in December 2021, the B. Braun Group announced that board member Dr. Joachim Schulz would be retiring and resigning from the B. Braun SE Executive Board. He will be succeeded by Dr. Jens von Lackum on April 1, 2022. For more information, visit:
Dr Jens von Lackum appointed to the Management Board of B. Braun SE